| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |